Post-concussion Syndrome and Chiropractic

Sponsor
Life University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06151184
Collaborator
(none)
10
1
1
12
0.8

Study Details

Study Description

Brief Summary

This proof-of-concept trial will explore the effects of manual chiropractic adjustments on nervous system function in individuals with post-concussion syndrome. This study will aim to recruit 10 individuals to receive 6 weeks of chiropractic care with 3 assessment periods. The participants will undergo a baseline assessment, mid-trial assessment, and post-trial assessment. The participants will wear an electroencephalography (EEG) cap for a neural assessment during an event related potential. They will wear electrical diodes to measure electrocardiography (ECG), impedance cardiography (ICG), and electrodermal activity (EDA) throughout the study and during an orthostatic challenge. Additional sensors will be placed on the participant to measure interlimb symmetry patterns during gait while walking on a treadmill.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Chiropractic adjustment
N/A

Detailed Description

Participants enrolled in the study will take a screening questionnaire to first determine eligibility. Once qualified, each individual will undergo a physical exam by a state licensed chiropractor to determine if there are any contraindications to undergo chiropractic care throughout the duration of the study. Each participant will receive 6 weeks of chiropractic care and will be assessed at weeks 0, 2, and 6 at the Dr. Sid E Williams Center for Chiropractic Research. Each participant will perform a number of tests to determine the evaluated function of their nervous system. In total, 3 different tests will be performed by the participant during an assessment visit that will take approximately 2.5 - 3 hours. During the assessments, each individual will be wearing electrical diodes to continually monitor

ECG, ICG, and EDA. The specific assessments will be as follows:
  1. Wearing an EEG net and then perform an event related potential after a baseline recording

  2. Performing an orthostatic challenge while measuring ECG, ICG, and EDA

  3. Wearing motion sensors while walking at a comfortable pace on a treadmill to evaluate interlimb symmetry and gait dynamics

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The intervention for this proof-of-concept trial is chiropractic manual adjustments. Participants will undergo chiropractic care from a state licensed chiropractor. Each individual's care plan will be determined by that individual and their specific field doctor for frequency of visits and type of chiropractic technique used. Participants will undergo 6 weeks of chiropractic for this study.The intervention for this proof-of-concept trial is chiropractic manual adjustments. Participants will undergo chiropractic care from a state licensed chiropractor. Each individual's care plan will be determined by that individual and their specific field doctor for frequency of visits and type of chiropractic technique used. Participants will undergo 6 weeks of chiropractic for this study.
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effects of Chiropractic Manual Adjustments on Nervous System Function in Individuals With Post-concussion Syndrome: a Proof of Concept Trial
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Post-concussion syndrome participants

Post-concussion syndrome participants will all receive manual chiropractic adjustment interventions.

Procedure: Chiropractic adjustment
6 weeks of chiropractic care, with frequency and type of procedures determined by field clinician after initial examination.

Outcome Measures

Primary Outcome Measures

  1. Recruitment rate [through study completion, an average of 1 year]

    Length of time required to recruit target number of participants

  2. Participant adherence rate [through study completion, an average of 1 year]

    Proportion of participants able to adhere to the testing & treatment schedule

  3. Participant tolerability rate [through study completion, an average of 1 year]

    Proportion of participants able to perform all aspects of the testing regimen

  4. Participant retention rate [through study completion, an average of 1 year]

    Proportion of enrolled participants who complete the full testing regimen

  5. Acceptability of treatment regimen for participants [Week 6]

    8-item Theoretical Framework of Acceptability questionnaire

Secondary Outcome Measures

  1. EEG resting state broadband power [Day 1]

    64-channel hydronet cap

  2. EEG resting state broadband power [Week 2]

    64-channel hydronet cap

  3. EEG resting state broadband power [Week 6]

    64-channel hydronet cap

  4. EEG resting state functional connectivity [Day 1]

    64-channel hydronet cap

  5. EEG resting state functional connectivity [Week 2]

    64-channel hydronet cap

  6. EEG resting state functional connectivity [Week 6]

    64-channel hydronet cap

  7. EEG evoked latency [Day 1]

    64-channel hydronet cap during auditory oddball task

  8. EEG evoked latency [Week 2]

    64-channel hydronet cap during auditory oddball task

  9. EEG evoked latency [Week 6]

    64-channel hydronet cap during auditory oddball task

  10. ECG mean interbeat interval [Day 1]

    3 sensors on torso

  11. ECG mean interbeat interval [Week 2]

    3 sensors on torso

  12. ECG mean interbeat interval [Week 6]

    3 sensors on torso

  13. ECG respiratory sinus arrhythmia (RSA) [Day 1]

    3 sensors on torso

  14. ECG respiratory sinus arrhythmia (RSA) [Week 2]

    3 sensors on torso

  15. ECG respiratory sinus arrhythmia (RSA) [Week 6]

    3 sensors on torso

  16. ECG de-trended fluctuation analysis [Day 1]

    3 sensors on torso

  17. ECG de-trended fluctuation analysis [Week 2]

    3 sensors on torso

  18. ECG de-trended fluctuation analysis [Week 6]

    3 sensors on torso

  19. Impedance cardiogram (ICG) pre-ejection period (PEP) [Day 1]

    2 sensors on chest and 2 sensors on back

  20. Impedance cardiogram (ICG) pre-ejection period (PEP) [Week 2]

    2 sensors on chest and 2 sensors on back

  21. Impedance cardiogram (ICG) pre-ejection period (PEP) [Week 6]

    2 sensors on chest and 2 sensors on back

  22. Impedance cardiogram (ICG) initial systolic time interval (ISTI) [Day 1]

    2 sensors on chest and 2 sensors on back

  23. Impedance cardiogram (ICG) initial systolic time interval (ISTI) [Week 2]

    2 sensors on chest and 2 sensors on back

  24. Impedance cardiogram (ICG) initial systolic time interval (ISTI) [Week 6]

    2 sensors on chest and 2 sensors on back

  25. Electrodermal activity (EDA) non-specific skin conductance responses (SCR) [Day 1]

    2 sensors on first and second digits of non-dominant hand

  26. Electrodermal activity (EDA) non-specific skin conductance responses (SCR) [Week 2]

    2 sensors on first and second digits of non-dominant hand

  27. Electrodermal activity (EDA) non-specific skin conductance responses (SCR) [Week 6]

    2 sensors on first and second digits of non-dominant hand

  28. Electrodermal activity (EDA) skin conductance level (SCL) [Day 1]

    2 sensors on first and second digits of non-dominant hand

  29. Electrodermal activity (EDA) skin conductance level (SCL) [Week 2]

    2 sensors on first and second digits of non-dominant hand

  30. Electrodermal activity (EDA) skin conductance level (SCL) [Week 6]

    2 sensors on first and second digits of non-dominant hand

  31. Composite Autonomic Symptom Score (COMPASS-31) [Day 0]

    31-item questionnaire

  32. Composite Autonomic Symptom Score (COMPASS-31) [Day 1]

    31-item questionnaire

  33. Composite Autonomic Symptom Score (COMPASS-31) [Week 2]

    31-item questionnaire

  34. Composite Autonomic Symptom Score (COMPASS-31) [Week 6]

    31-item questionnaire

  35. Patient-Reported Outcomes Measurement Information System (PROMIS-29) [Day 0]

    29-item questionnaire

  36. Patient-Reported Outcomes Measurement Information System (PROMIS-29) [Day 1]

    29-item questionnaire

  37. Patient-Reported Outcomes Measurement Information System (PROMIS-29) [Week 2]

    29-item questionnaire

  38. Patient-Reported Outcomes Measurement Information System (PROMIS-29) [Week 6]

    29-item questionnaire

  39. Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog-8) [Day 0]

    8-item questionnaire

  40. Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog-8) [Day 1]

    8-item questionnaire

  41. Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog-8) [Week 2]

    8-item questionnaire

  42. Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog-8) [Week 6]

    8-item questionnaire

  43. Perceived Stress Scale (PSS) [Day 0]

    10-item questionnaire

  44. Perceived Stress Scale (PSS) [Day 1]

    10-item questionnaire

  45. Perceived Stress Scale (PSS) [Week 2]

    10-item questionnaire

  46. Perceived Stress Scale (PSS) [Week 6]

    10-item questionnaire

  47. Post-Concussion Symptom Scale [Day 0]

    22-item questionnaire

  48. Post-Concussion Symptom Scale [Day 1]

    22-item questionnaire

  49. Post-Concussion Symptom Scale [Week 2]

    22-item questionnaire

  50. Post-Concussion Symptom Scale [Week 6]

    22-item questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 or older

  • Diagnosed by a physician with PCS OR self-identifies as having a concussion based on responses to the HELPS screening tool

  • Has at least 3 of the following chronic symptoms at least 3 months since concussion: headache; dizziness; insomnia; fatigue; concentration difficulty; memory difficulty; intolerance to stress, emotions, and alcohol; irritability

  • Able to understand and communicate in English

  • Able to make informed decisions without assistance

  • Can wear an EEG net for 40 minutes

  • Can sit quietly for at least 15 minutes

  • Capable of walking on a treadmill at a comfortable pace for 10 minutes consecutively

  • Capable of moving from a supine to standing to supine position quickly and safely

  • Able to wear multiple electrodes placed on chest, back, and fingertips

  • Able to wear multiple sensors placed on head, back, pelvis, hands, arms, and legs

  • Has not had a chiropractic adjustment within the last three months

  • Has not received any other interventions within the past three months such as osteopathic spinal manipulation, physical therapy rehabilitation or manipulation, massage, body movement therapies, or acupuncture

  • Able to provide the name and contact of a medical care provider (i.e., primary physician, therapist, or neurologist) they have received care from recently or in the past

Exclusion Criteria:
  • Diagnosed with a serious mental disorder such as schizophrenia or bipolar disorder

  • Has malignant hypertension, which is a condition whereby their blood pressure rises suddenly and quickly

  • Has a known condition that causes syncope with postural changes, such as POTS

  • Has an implanted device (i.e., pacemaker)

  • Has a physical disability affecting their gait

  • Has a history of previous surgery or injury to the musculoskeletal structures or skull in the past three months

  • Has a prosthetic for any extremity

  • Has a hearing impairment or uses a hearing aid

  • History of stroke

  • Taking short-acting benzodiazepines, which includes midazolam and triazolam

  • Involved with current litigation related to a physical health-related injury

  • Untreated diagnosed osteoporosis or articular instability such as atlanto-axial instability

  • Currently pregnant

  • Unwilling to wash hair/head and remove hair products, accessories, braids, or wigs for assessment appointments

  • Deemed high-risk using the Columbia-Suicide Severity Rating Scale (C-SSRS) and referred for further evaluation (assessed at initial session in lab)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dr. Sid E. Williams Center for Chiropractic Research Atlanta Georgia United States 30308

Sponsors and Collaborators

  • Life University

Investigators

  • Principal Investigator: Daimeyon Williams, Life University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Life University
ClinicalTrials.gov Identifier:
NCT06151184
Other Study ID Numbers:
  • I-0025
First Posted:
Nov 30, 2023
Last Update Posted:
Nov 30, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Life University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2023